Compensatory enlargement in transplant coronary artery disease: an intravascular ultrasound study. 2006

Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
Department of Cardiology, Peking University Third Hospital, Beijing100083, China.

BACKGROUND It is unclear to what extent the "Glagov phenomenon" occurs in transplant coronary artery disease (TCAD). The objective of this study was to evaluate the relationship between intimal hyperplasia and compensatory enlargement in TCAD. METHODS Intravascular ultrasound imaging was performed on 190 cardiac transplant recipients at (1.4 +/- 0.6) months and again (12.1 +/- 0.7) months after cardiac transplantation. Studies 1 year apart were matched at 625 sites. There were 345 coronary artery sites that had an increase in intimal area > 10% from baseline to one year, and this comprised the data set of the present study. RESULTS At the first year, 91% of coronary artery sites with intimal growth had a total cross-sectional area stenosis < or = 40%, but 38% of the sites showed a decrease of > 10% in lumen area. Receiver operating characteristic curve demonstrated that the change in cross-sectional area stenosis cut-off level at year 1 was 8% with a sensitivity of 75% and a specificity of 82% in predicting lumen loss. At a total cross-sectional area stenosis of 20%, sensitivity was 65% with a specificity of 81% in predicting lumen loss. CONCLUSIONS In TCAD, vessel enlargement as a compensatory mechanism for plaque growth is generally inadequate. Instead of continued vessel expansion, luminal narrowing develops when there is more than 8% cross-sectional area filled with intimal hyperplasia. In distinction to native coronary artery atherosclerotic disease, the transition point in transplant vasculopathy where the lumen is diminished by increasing intimal growth, occurs at a lower threshold, 20% vs 40% of vessel cross-sectional area.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
February 1997, Circulation,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
June 1996, Journal of the American College of Cardiology,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
August 1996, Angiology,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
July 1997, European heart journal,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
April 2000, International journal of cardiac imaging,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
December 1995, American heart journal,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
March 1999, Current opinion in cardiology,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
August 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
November 1992, Journal of the American College of Cardiology,
Hai-yan Li, and Koji Tanaka, and Brandy Oeser, and Brett Wertman, and Jon A Kobashigawa, and Jonathan M Tobis
February 1996, Circulation,
Copied contents to your clipboard!